BBH vs IVV
VanEck Biotech ETF vs iShares Core S&P 500 ETF
Which is better, BBH or IVV?
Large Cap Growth against Large Cap Blend.
IVV has a lower expense ratio. BBH led over 1Y and the full window, IVV over 3Y and 5Y. IVV is less concentrated, with 37.9% of the fund in its ten largest positions against 72.0%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | BBH | IVV |
|---|---|---|
| Expense Ratio | 0.35% | 0.03%Best |
| AUM | $406M | $886.7B |
| Dividend Yield | 0.46% | 1.10% |
| Holdings | 25 | 508 |
| YTD Return | +28.12%Best | +13.86% |
| 1Y Return | +47.80%Best | +21.57% |
| 3Y Return (annualized) | +15.20% | +21.48%Best |
| 5Y Return (annualized) | +2.56% | +12.88%Best |
| Volatility (annualized) | 29.1% | 15.1%Best |
| Max Drawdown | -67.2% | -56.5%Best |
| $10,000 over 5 years | $11,347 | $18,327Best |
| Top 10 Weight | 72.0% | 37.9%Best |
| Fund Family | VanEck | iShares by BlackRock (US) |
| Category | Equity | Equity |
| Style | Large Cap Growth | Large Cap Blend |
| Inception | Dec 20, 2011 | May 15, 2000 |
Volatility and max drawdown are measured over the window both funds cover: May 19, 2000 to Sep 3, 2026 (26.3 years).
BBH vs IVV growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 26.3 years both funds cover.
BBH vs IVV Performance
VanEck Biotech ETF (BBH) is an ETF from VanEck and iShares Core S&P 500 ETF (IVV) is an ETF from iShares by BlackRock (US). Over the past year BBH returned +47.80% while IVV returned +21.57%. Year to date, BBH is up 28.12% versus a gain of 13.86% for IVV.
Over three years, BBH compounded at +15.20% per year against +21.48% for IVV; over five years the annualized figures are +2.56% and +12.88% respectively. Across the full 26-year window we track, BBH has the edge at +13.82% annualized vs +7.03%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
BBH has been the more volatile fund, with annualized monthly volatility of 29.1% compared with 15.1% for IVV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -67.2% for BBH and -56.5% for IVV. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.50. They move together some of the time, and apart the rest.
Fees and Cost Over Time
BBH charges 0.35% per year while IVV charges 0.03%. On a $10,000 position that is $35 vs $3 annually, a gap of $32 per year that compounds over a long holding period. On income, BBH currently yields 0.46% against 1.10% for IVV.
Holdings Overlap
62.2% of BBH's money is in holdings IVV also owns. 1.1% of IVV's money is in holdings BBH also owns.
The two portfolios partly overlap.
10 positions in common, counted across the 24 positions we hold weights for in BBH and 505 in IVV, against full books of 25 and 508.
What only one of them owns
Our book lists 487 positions for IVV that do not appear in our book for BBH (98.2% of the fund), and 11 for BBH that do not appear in IVV (30.3%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in BBH | Weight in IVV | Difference |
|---|---|---|---|
| AMGNAmgen Inc. | 16.58% | 0.33% | 16.25% |
| GILDGilead Sciences | 12.87% | 0.25% | 12.62% |
| VRTXNvaesrtex Pharmaceuticals Inc | 8.58% | 0.18% | 8.40% |
| REGNRegeneron Pharmaceuticals, Inc. | 7.39% | 0.12% | 7.27% |
| IQVIqvia Holdings Inc | 5.08% | 0.06% | 5.02% |
| BIIBBiogen Inc. Com | 3.35% | 0.05% | 3.30% |
| MRNAModerna therapeutics | 2.61% | 0.03% | 2.58% |
| INCYIncyte Corp. | 2.54% | 0.03% | 2.51% |
| CRLCharles River Laboratories International Inc | 1.67% | 0.02% | 1.65% |
| TECHBio-Techne Corp | 1.52% | 0.02% | 1.50% |
62.2% of BBH is already inside IVV.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, BBH or IVV?
BBH has an expense ratio of 0.35% while IVV charges 0.03%. IVV is the cheaper option, by $32 a year on a $10,000 investment.
Which performed better, BBH or IVV?
Over the past year BBH returned +47.80% vs +21.57% for IVV, so BBH leads on 1-year performance. Over the longest common window we track (26 years), BBH annualized +13.82% vs +7.03% for IVV. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, BBH or IVV?
BBH has been the more volatile fund at 29.1% annualized versus 15.1% for IVV. Worst drawdown: BBH -67.2% vs IVV -56.5%.
Should I hold both BBH and IVV?
BBH and IVV have a monthly-return correlation of 0.50, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
What is the holdings overlap between BBH and IVV?
62.2% of BBH's money is in holdings IVV also owns. 1.1% of IVV's is in holdings BBH also owns. They hold 10 positions in common, counted across the 24 positions we hold weights for in BBH and 505 in IVV.
Which pays a higher dividend, BBH or IVV?
BBH yields 0.46% while IVV yields 1.10%, so IVV currently pays the higher dividend yield.
Is IVV better than BBH?
IVV has a lower expense ratio. BBH led over 1Y and the full window, IVV over 3Y and 5Y. IVV is less concentrated, with 37.9% of the fund in its ten largest positions against 72.0%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.